Patents Assigned to MP-1 Inc.
  • Patent number: 6734192
    Abstract: A pharmaceutical composition comprising therapeutically effective quantities of calcium channel blockers in combination with quinolines. In preferred embodiments, the invention further comprises quercetin. The components combine and interact in a manner to effectively treat viral infections.
    Type: Grant
    Filed: August 23, 2000
    Date of Patent: May 11, 2004
    Assignee: MP-1 Inc.
    Inventor: Robert H. Keller